Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
87.8M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
7.09M
-
Shares change
-
-44.3K
-
Total reported value, excl. options
-
$12.9M
-
Value change
-
-$163K
-
Number of buys
-
24
-
Number of sells
-
-13
-
Price
-
$1.82
Significant Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q1 2024
51 filings reported holding CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q1 2024.
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.09M shares
of 87.8M outstanding shares and own 8.07% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (1.9M shares), VANGUARD GROUP INC (922K shares), AWM Investment Company, Inc. (650K shares), Alyeska Investment Group, L.P. (500K shares), Timelo Investment Management Inc. (481K shares), CORSAIR CAPITAL MANAGEMENT, L.P. (285K shares), HOHIMER WEALTH MANAGEMENT, LLC (225K shares), CARLSON CAPITAL L P (214K shares), AMERICAN FINANCIAL GROUP INC (205K shares), and Kestra Advisory Services, LLC (199K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.